Cargando…
microRNA-Dependent Modulation of Genes Contributes to ESR1's Effect on ERα Positive Breast Cancer
Background: Dysregulation of ESR1 accounts for endocrine therapy resistance and metastasis of ERα positive breast cancer. However, the underlying molecular mechanism of ESR1 in ERα positive breast cancer remains insufficiency. Notably, to date, a comprehensive miRNA-mRNA regulatory network involved...
Autores principales: | Gao, Shan, Ding, Bisha, Lou, Weiyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243797/ https://www.ncbi.nlm.nih.gov/pubmed/32500028 http://dx.doi.org/10.3389/fonc.2020.00753 |
Ejemplares similares
-
CASK Silence Overcomes Sorafenib Resistance of Hepatocellular Carcinoma Through Activating Apoptosis and Autophagic Cell Death
por: Ding, Bisha, et al.
Publicado: (2021) -
MicroRNAs in cancer metastasis and angiogenesis
por: Lou, Weiyang, et al.
Publicado: (2017) -
Prevalence of ESR1 Mutation in Chinese ER-Positive Breast Cancer
por: Zhu, Wenzhen, et al.
Publicado: (2020) -
Clinical Implications of ESR1 Mutations in Hormone Receptor-Positive Advanced Breast Cancer
por: Reinert, Tomas, et al.
Publicado: (2017) -
High Expression of Pseudogene PTTG3P Indicates a Poor Prognosis in Human Breast Cancer
por: Lou, Weiyang, et al.
Publicado: (2019)